FDA Calendar for Anadys Pharmaceuticals, Inc. (ANDS)

| Register (free)
Anadys Pharmaceuticals, Inc., is a biopharmaceutical company focused to develop medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA773, an oral Toll-like receptor 7 (TLR7) agonist prodrug for the treatment of hepatitis C and cancer. Both ANA598 and ANA773 were discovered at Anadys and are wholly owned assets of Anadys. With ANA598 the Company is focused on developing a direct antiviral, meaning a product candidate that acts by directly interacting with, and blocking the function of, a component of the virus. With ANA773, Anadys is stimulating the patient’s own immune system to block cells infected with the hepatitis C virus from further amplifying the infection by producing more virus particles.

Around The Net


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
This company currently does not have any drugs. If you would like to create one please click here.


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

$0.00
0
1/1/0001 12:00:00 AM

Sponsors

Other Links